Compare Vir Biotechnology Inc. Common Stock (VIR) vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF (VTIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vir Biotechnology Inc. Common Stock vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $49.94 (market cap $73.20B). The key difference: Vanguard Sht-Term Inflation-Protected Sec Idx ETF is far larger — about 40.7× Vir Biotechnology Inc. Common Stock's market cap, and Vanguard Sht-Term Inflation-Protected Sec Idx ETF is more actively traded (2,410,205 versus 1,782,836). Which is the better fit depends on your goals — on Pluang, investors hold Vir Biotechnology Inc. Common Stock for 0 Days and Vanguard Sht-Term Inflation-Protected Sec Idx ETF for 92 Days on average.
| VIR | VTIP | |
|---|---|---|
Market Cap | $1.80B | $73.20B |
Volume | 1,782,836 | 2,410,205 |
Sector | Health | — |
52-Week High | $11.78 | $50.46 |
52-Week Low | $5.12 | $48.38 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $1.36B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VTIP, a Vanguard short-term inflation-protected securities ETF, trades at $48.46, down 0.06% on the day. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators are neutral. The fund focuses on short-duration TIPS to hedge inflation with minimal interest-rate risk, attracting institutional interest as seen in recent filings. News highlights its role in protecting against inflation spikes and Fed rate hikes.
The outlook for VTIP is supported by persistent inflation and high real yields, offering a defensive allocation. Risks include interest rate volatility and potential underperformance if inflation recedes. Institutional accumulation suggests confidence, but investors should weigh the fund's low sensitivity against broader bond market shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →About Vanguard Sht-Term Inflation-Protected Sec Idx ETF
The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →
